期刊
LANCET
卷 390, 期 10110, 页码 2383-2396出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(17)31462-9
关键词
-
资金
- Swedish Research Council [839-2008-7496]
- Swedish Cancer Society [CAN 2015/460]
- National Institute for Health Research
- Institute for Cancer Research Biomedical Research Centre
- Karolinska Institutet Distinguished Professor Award [D-02418/2010]
Oesophageal cancer is a clinically challenging disease that requires a multidisciplinary approach. Extensive treatment might be associated with a considerable decline in health-related quality of life and yet still a poor prognosis. In recent decades, prognosis has gradually improved in many countries. Endoscopic procedures have increasingly been used in the treatment of premalignant and early oesophageal tumours. Neoadjuvant therapy with chemotherapy or chemoradiotherapy has supplemented surgery as standard treatment of locally advanced oesophageal cancer. Surgery has become more standardised and centralised. Several therapeutic alternatives are available for palliative treatment. This Seminar aims to provide insights into the current clinical management, ongoing controversies, and future needs in oesophageal cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据